ARTICLE | Clinical News
IL-12: Hopes to restart clinical trials this fall. A Phase II study in advanced kidney cancer was suspended in June after the hospitalization of 10 patients and
August 21, 1995 7:00 AM UTC
Genetics Institute Inc.(GENIZ), Cambridge, Mass. Product: IL-12 Indication: Cancer and HIV Status: Hopes to restart clinical trials this fall. A Phase II study in advanced kidney cancer was suspended ...